Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

97 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Longitudinal Evaluation of Biomarkers in Wound Fluids from Venous Leg Ulcers and Split-thickness Skin Graft Donor Site Wounds Treated with a Protease-modulating Wound Dressing.
Mikosiński J, Kalogeropoulos K, Bundgaard L, Larsen CA, Savickas S, Moldt Haack A, Pańczak K, Rybołowicz K, Grzela T, Olszewski M, Ciszewski P, Sitek-Ziółkowska K, Twardowska-Saucha K, Karczewski M, Rabczenko D, Segiet A, Buczak-Kula P, Schoof EM, Eming SA, Smola H, Auf dem Keller U. Mikosiński J, et al. Among authors: rabczenko d. Acta Derm Venereol. 2022 Dec 13;102:adv00834. doi: 10.2340/actadv.v102.325. Acta Derm Venereol. 2022. PMID: 36250733 Free PMC article.
An observational study of wounds treated with hydro-responsive wound dressings.
Goedecke F, Bühring J, Kratz A, Schweiger W, Köhle C, Waidner U, Riedel T, Walter A, Skrowny P, Rothenaicher G, Segiet A, Rabczenko D, Rogers A, Rippon M. Goedecke F, et al. Among authors: rabczenko d. J Wound Care. 2022 Dec 2;31(12):1029-1038. doi: 10.12968/jowc.2022.31.12.1029. J Wound Care. 2022. PMID: 36475853
First-in-human study of CPL207280, a novel G-protein-coupled receptor 40/free fatty acid receptor 1 agonist, in healthy volunteers after single and multiple administration.
Bazydło-Guzenda K, Jarus-Dziedzic K, Gierczak-Pachulska A, Buda P, Rudzki PJ, Buś-Kwaśnik K, Juszczyk E, Tratkiewicz E, Rabczenko D, Segiet-Święcicka A, Wieczorek M. Bazydło-Guzenda K, et al. Among authors: rabczenko d. Diabetes Obes Metab. 2024 Apr;26(4):1376-1385. doi: 10.1111/dom.15439. Epub 2024 Jan 11. Diabetes Obes Metab. 2024. PMID: 38204407
Regional differences in physicians' behavior and factors influencing the intensity of PCSK9 inhibitor therapy with alirocumab: a subanalysis of the ODYSSEY APPRISE study.
Banach M, Lewek J, Pol K, Rabczenko D, Balanescu SM, Blaha V, Ceska R, Jankowski P, Surma S, Kolovou G, Liberopoulos E, Mitu F, Mitu M, Naji FH, Paragh G, Popławska M, Vrablik M, Pella D. Banach M, et al. Among authors: rabczenko d. Front Cardiovasc Med. 2023 Jun 19;10:1206551. doi: 10.3389/fcvm.2023.1206551. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37404744 Free PMC article.
Safety, tolerability, and efficacy of a widely available nusinersen program for Polish children with Spinal Muscular Atrophy.
Kotulska K, Chmielewski D, Mazurkiewicz-Bełdzińska M, Tomaszek K, Pierzchlewicz K, Rabczenko D, Przysło Ł, Biedroń A, Czyżyk E, Steinborn B, Pietruszewski J, Boćkowski L, Cichosz D, Dudzińska M, Gadowska E, Młynarczyk E, Jasiński M, Masztalerz A, Kempisty A, Kostera-Pruszczyk A. Kotulska K, et al. Among authors: rabczenko d. Eur J Paediatr Neurol. 2022 Jul;39:103-109. doi: 10.1016/j.ejpn.2022.06.001. Epub 2022 Jun 5. Eur J Paediatr Neurol. 2022. PMID: 35738181
97 results